Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Researchers uncover genetic evidence of paratyphoid fever and relapsing fever in 1812 French soldiers, challenging the long-held view that typhus alone accounted for the Grande Armée's toll.
U.S. and Australia sign critical minerals deal to reduce China's dominance in refining, but local communities raise environmental concerns.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Researchers uncover genetic evidence of paratyphoid fever and relapsing fever in 1812 French soldiers, challenging the long-held view that typhus alone accounted for the Grande Armée's toll.
U.S. and Australia sign critical minerals deal to reduce China's dominance in refining, but local communities raise environmental concerns.